Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Grdina

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Oncology|December 6, 2002
Radioprotectants: current status and new directionsDavid J Grdina, Jeffrey S Murley, Yasushi Kataoka
Radiation Research|April 24, 2014
Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugsRichard C Miller, Jeffrey S Murley, David J Grdina
Biochimica Et Biophysica Acta|March 14, 2003
Oral administration is as effective as intraperitoneal administration of amifostine in decreasing nitroxide EPR signal decay in vivoMartyna Elas, Adrian Parasca, David J Grdina, et al.
Military Medicine|March 5, 2002
Relationships between cytoprotection and mutation prevention by WR-1065David J Grdina, Jeffrey S Murley, Yasushi Kataoka, et al.
Radiation Research|May 12, 2017
Andrographis paniculata Diterpenoids Protect against Radiation-Induced Transformation in BALB/3T3 CellsDanupon Nantajit, Suwimol Jetawattana, Tawit Suriyo, et al.
Plos One|December 10, 2015
The Increase in Animal Mortality Risk following Exposure to Sparsely Ionizing Radiation Is Not Linear Quadratic with DoseBenjamin M Haley, Tatjana Paunesku, David J Grdina, et al.
Radiation Research|August 29, 2007
Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugsYasushi Kataoka, Jeffrey S Murley, Kenneth L Baker, et al.
Seminars in Radiation Oncology|March 28, 2002
Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cellsDavid J Grdina, Jeffrey S Murley, Yasushi Kataoka, et al.
Radiation Research|August 17, 2017
TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive ResponseJeffrey S Murley, Richard C Miller, Ralph R Weichselbaum, et al.
Free Radical Biology & Medicine|April 17, 2018
ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive responseJeffrey S Murley, Jack L Arbiser, Ralph R Weichselbaum, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Oncology|December 6, 2002
Radioprotectants: current status and new directionsDavid J Grdina, Jeffrey S Murley, Yasushi Kataoka
Radiation Research|April 24, 2014
Metformin exhibits radiation countermeasures efficacy when used alone or in combination with sulfhydryl containing drugsRichard C Miller, Jeffrey S Murley, David J Grdina
Biochimica Et Biophysica Acta|March 14, 2003
Oral administration is as effective as intraperitoneal administration of amifostine in decreasing nitroxide EPR signal decay in vivoMartyna Elas, Adrian Parasca, David J Grdina, et al.
Military Medicine|March 5, 2002
Relationships between cytoprotection and mutation prevention by WR-1065David J Grdina, Jeffrey S Murley, Yasushi Kataoka, et al.
Radiation Research|May 12, 2017
Andrographis paniculata Diterpenoids Protect against Radiation-Induced Transformation in BALB/3T3 CellsDanupon Nantajit, Suwimol Jetawattana, Tawit Suriyo, et al.
Plos One|December 10, 2015
The Increase in Animal Mortality Risk following Exposure to Sparsely Ionizing Radiation Is Not Linear Quadratic with DoseBenjamin M Haley, Tatjana Paunesku, David J Grdina, et al.
Radiation Research|August 29, 2007
Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugsYasushi Kataoka, Jeffrey S Murley, Kenneth L Baker, et al.
Seminars in Radiation Oncology|March 28, 2002
Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cellsDavid J Grdina, Jeffrey S Murley, Yasushi Kataoka, et al.
Radiation Research|August 17, 2017
TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive ResponseJeffrey S Murley, Richard C Miller, Ralph R Weichselbaum, et al.
Free Radical Biology & Medicine|April 17, 2018
ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive responseJeffrey S Murley, Jack L Arbiser, Ralph R Weichselbaum, et al.
Pageof 5